A tri-metallic palladium complex with breast cancer stem cell potency

Area of Science:

• Inorganic Chemistry
• Cancer Biology
• Medicinal Chemistry

Background:

• Cancer stem cells (CSCs) are a subpopulation of cancer cells responsible for tumor recurrence and metastasis.
• Targeting CSCs is crucial for developing effective cancer therapies.
• Palladium complexes have shown promise as anticancer agents.

Purpose of the Study:

• To investigate the efficacy of a novel multi-nuclear, triangular-shaped palladium(II) complex against cancer cells and CSCs.
• To elucidate the mechanism by which the palladium(II) complex induces cell death in CSCs.

Main Methods:

• Synthesis and characterization of the palladium(II) complex.
• In vitro cytotoxicity assays on bulk cancer cells and CSCs.
• Cellular uptake studies to determine localization within CSCs.
• DNA damage assays to assess genotoxicity.

Main Results:

• The palladium(II) complex demonstrated equipotent cytotoxicity against both bulk cancer cells and CSCs in the micromolar range.
• The complex was found to enter the nuclei of CSCs.
• Evidence of genomic DNA damage was observed in CSCs treated with the complex.
• Apoptosis was induced in CSCs.

Conclusions:

• The multi-nuclear palladium(II) complex is a potent agent against both cancer cells and CSCs.
• The complex exerts its anti-CSC effects through nuclear entry, DNA damage, and induction of apoptosis.
• This palladium(II) complex represents a promising candidate for further development as an anticancer therapeutic.